These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35413205)

  • 1. Potential role of d-
    Simic D; Nikolic Turnic T; Dimitrijevic A; Zivadinovic A; Milosevic-Stevanovic J; Djuric D; Zivkovic V; Jakovljevic V
    Can J Physiol Pharmacol; 2022 Jul; 100(7):629-636. PubMed ID: 35413205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome.
    Donà G; Sabbadin C; Fiore C; Bragadin M; Giorgino FL; Ragazzi E; Clari G; Bordin L; Armanini D
    Eur J Endocrinol; 2012 Apr; 166(4):703-10. PubMed ID: 22223702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.
    Pustotina O; Myers SH; Unfer V; Rasulova I
    Gynecol Obstet Invest; 2024; 89(2):131-139. PubMed ID: 38295772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.
    Galazis N; Galazi M; Atiomo W
    Gynecol Endocrinol; 2011 Apr; 27(4):256-62. PubMed ID: 21142777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H; Xing C; Zhang J; He B
    Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome.
    Baillargeon JP; Diamanti-Kandarakis E; Ostlund RE; Apridonidze T; Iuorno MJ; Nestler JE
    Diabetes Care; 2006 Feb; 29(2):300-5. PubMed ID: 16443877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome.
    Pericuesta E; Laguna-Barraza R; Ramos-Ibeas P; Gutierrez-Arroyo JL; Navarro JA; Vera K; Sanjuan C; Baixeras E; de Fonseca FR; Gutierrez-Adan A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open-label study.
    Kachhawa G; Senthil Kumar KV; Kulshrestha V; Khadgawat R; Mahey R; Bhatla N
    Int J Gynaecol Obstet; 2022 Aug; 158(2):278-284. PubMed ID: 34624138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index.
    Genazzani AD; Battipaglia C; Petrillo T; Piacquadio N; Ambrosetti F; Arnesano M; Semprini E; Sponzilli A; Tomatis V; Simoncini T
    Gynecol Endocrinol; 2022 Aug; 38(8):681-688. PubMed ID: 35748584
    [No Abstract]   [Full Text] [Related]  

  • 10. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.
    Laganà AS; Garzon S; Casarin J; Franchi M; Ghezzi F
    Trends Endocrinol Metab; 2018 Nov; 29(11):768-780. PubMed ID: 30270194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study.
    La Marca A; Grisendi V; Dondi G; Sighinolfi G; Cianci A
    Gynecol Endocrinol; 2015 Jan; 31(1):52-6. PubMed ID: 25268566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflections on inositol(s) for PCOS therapy: steps toward success.
    Nestler JE; Unfer V
    Gynecol Endocrinol; 2015 Jul; 31(7):501-5. PubMed ID: 26177098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients.
    Genazzani AD; Santagni S; Rattighieri E; Chierchia E; Despini G; Marini G; Prati A; Simoncini T
    Gynecol Endocrinol; 2014 Jun; 30(6):438-43. PubMed ID: 24601829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
    Nestler JE; Jakubowicz DJ; Reamer P; Gunn RD; Allan G
    N Engl J Med; 1999 Apr; 340(17):1314-20. PubMed ID: 10219066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and hormonal effects of a combined Myo-inositol and d-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS).
    Januszewski M; Issat T; Jakimiuk AA; Santor-Zaczynska M; Jakimiuk AJ
    Ginekol Pol; 2019; 90(1):7-10. PubMed ID: 30756365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity.
    Villeneuve MC; Ostlund RE; Baillargeon JP
    Metabolism; 2009 Jan; 58(1):62-8. PubMed ID: 19059532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome.
    Baillargeon JP; Iuorno MJ; Apridonidze T; Nestler JE
    Metab Syndr Relat Disord; 2010 Apr; 8(2):127-36. PubMed ID: 20156067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome.
    Cheang KI; Baillargeon JP; Essah PA; Ostlund RE; Apridonize T; Islam L; Nestler JE
    Metabolism; 2008 Oct; 57(10):1390-7. PubMed ID: 18803944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.
    Monastra G; Unfer V; Harrath AH; Bizzarri M
    Gynecol Endocrinol; 2017 Jan; 33(1):1-9. PubMed ID: 27898267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.
    Dinicola S; Chiu TT; Unfer V; Carlomagno G; Bizzarri M
    J Clin Pharmacol; 2014 Oct; 54(10):1079-92. PubMed ID: 25042908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.